# Irina Erenburg

> Irina Erenburg is the founder, president and CEO of AVAVA, a Waltham, Massachusetts medical aesthetics company behind MIRIA, a new class of dermatology laser built on the company's proprietary Focal Point Technology. A biomedical scientist turned serial entrepreneur, she earned a PhD from the Mount Sinai School of Medicine and got her start negotiating high-value deals inside Boston's largest hospital network, where she helped shepherd startups including Zeltiq Aesthetics. She has co-founded R2 Dermatology and Soltego and, in 2024, raised $35 million to commercialize AVAVA's technology for treating skin of every tone.

- **Role:** Founder, President & CEO at AVAVA, Inc.
- **Organizations:** AVAVA, Inc., Blossom Innovations, R2 Dermatology, Inc., Soltego, Inc., Partners HealthCare Office of Innovations
- **Education:** Bachelor of Arts, Brandeis University, PhD, Biomedical Science, Mount Sinai School of Medicine of New York University
- **Known for:** Founded AVAVA and brought MIRIA, a new class of aesthetic dermatology laser, to market, Raised $35 million in 2024 to fund commercial expansion, Helped shepherd Zeltiq Aesthetics as a Partners HealthCare deal-maker; Zeltiq was later acquired by Allergan for $2.4B

## Career timeline

- **Earlier** — Director of Strategic Transactions at Partners HealthCare Office of Innovations, handling high-value deals and startups tied to Massachusetts General Hospital, including Zeltiq Aesthetics
- **Earlier** — Co-founded and joined the board of R2 Dermatology, Inc. and Soltego, Inc.
- **Earlier** — President at Blossom Innovations
- **2024** — Launched MIRIA at ASLMS 2024, the energy-based medicine and science conference
- **2024** — Closed $35 million in financing ($25M Series C plus $10M growth capital from Catalio Capital Management) to expand commercialization of MIRIA

## Achievements

- Founded AVAVA and brought MIRIA, a new class of aesthetic dermatology laser, to market
- Raised $35 million in 2024 to fund commercial expansion
- Helped shepherd Zeltiq Aesthetics as a Partners HealthCare deal-maker; Zeltiq was later acquired by Allergan for $2.4B
- Co-founded R2 Dermatology and Soltego
- Recruited laser medicine pioneer Dr. Rox Anderson to AVAVA's board of directors

## Latest updates

- **2024-04** — AVAVA launched MIRIA at ASLMS 2024, the energy-based medicine and science conference.
- **2024-06** — AVAVA closed $35 million in financing, including a $25M Series C and $10M in growth capital from Catalio Capital Management, to support commercial expansion.

## Links

- Website: https://avavaskin.com
- LinkedIn: http://www.linkedin.com/in/irina-erenburg-0124598
- Instagram: https://www.instagram.com/irina.erenburg/

---

Profile page: https://yespress.io/irina-erenburg
Published by YesPress — https://yespress.io
Last updated: 2026-07-17